Asia-Pacific Bioprocessing Facilities Report 2020
発行: IMAPAC PTE. LTD
ページ情報: 英文 300 Pages
The Biologics industry is evolving at an unprecedented rate by demanding for new and improved technologies to reduce cost and increase efficiency. The world is seeing an increase in Biopharma facilities, especially in Asia to meet the growing demands of biologic drugs. Yet, the number one factor reported to cause capacity constraints at bioprocessing facilities in the near future is facility constraints.
Hence, IMAPAC has put together a comprehensive report on 65+ Bioprocessing facilities in the past ten years that have been constructed in the Asia- Pacific region including countries such as China, India, Korea, Japan, SEA, Australia. This report will provide detailed analysis from their manufacturing capabilities, Process Technologies to key details on their Facility Construction Design. We will be providing information straight from our interaction with top players in the industry and key management of companies, on how their facilities provide them with the flexibility to expand their manufacturing capabilities while cutting cost.
Are you also looking to expand your operations to meet the growing global demands? If you would like to learn from the successful players in the industry and not repeat the same mistakes as some of your competitors, check out the full report now.